Future Oncology, Volume 19, Issue 4 (2023)

Browse this journal
Sample our Health and Social Care journals, sign in here to start your FREE access for 14 days

Future Oncology, Volume 19, Issue 4 (2023)

See all volumes and issues
Vol 20, 2024 Volume 19, 2023 Vol 18, 2022 Vol 17, 2021 Vol 16, 2020 Vol 15, 2019 Vol 14, 2018 Vol 13, 2017 Vol 12, 2016 Vol 11, 2015 Vol 10, 2014 Vol 9, 2013 Vol 8, 2012 Vol 7, 2011 Vol 6, 2010 Vol 5, 2009 Vol 4, 2008 Vol 3, 2007 Vol 2, 2006 Vol 1, 2005
Download citations Download PDFs Download issue

Editorial

Editorial
The CLIP1–LTK fusion: anew oncogenic driver in non-small-cell lung cancer?
Rebecca Ibrahim, Claude Chahine, Tony Felefly, Nadine Khalife & Khalil Saleh
Pages: 273-275
Published online: 21 Mar 2023
First Page PreviewforThe CLIP1–LTK fusion: anew oncogenic driver in non-small-cell lung cancer? | Full Text | References | PDF (1.2 MB) | EPUB
  • 136 Views
  • 0 CrossRef citations
  • 0Altmetric

Letter to the Editor

Letter to the Editor
Significant heterogeneity of published literature comparing radiofrequency ablation versus stereotactic body radiation therapy for hepatocellular carcinoma
Aleena Malik, Meghan P Jairam, Ronald Chow, Seyed A Mirshahvalad, Patrick Veit-Haibach & Charles B Simone II
Pages: 277-278
Published online: 14 Mar 2023
CitationforSignificant heterogeneity of published literature comparing radiofrequency ablation versus stereotactic body radiation therapy for hepatocellular carcinoma | Full Text | References | PDF (1.2 MB) | EPUB
  • 41 Views
  • 1 CrossRef citations
  • 0Altmetric

Meta-Analysis

Article
Radiofrequency ablation versus stereotactic body radiation therapy for hepatocellular carcinoma: a meta-regression
Aleena Malik, Meghan P Jairam, Ronald Chow, Seyed A Mirshahvalad, Patrick Veit-Haibach & Charles B Simone II
Pages: 279-287
Published online: 14 Mar 2023
AbstractforRadiofrequency ablation versus stereotactic body radiation therapy for hepatocellular carcinoma: a meta-regression | Full Text | References | PDF (1.5 MB) | EPUB | Supplemental
  • 65 Views
  • 0 CrossRef citations
  • 0Altmetric

Letter in Reply

Reply
In reply to: Significant heterogeneity of published literature comparing radiofrequency ablation versus stereotactic body radiation therapy for hepatocellular carcinoma
Huimei Zhang & Yehuan Sun
Pages: 289-290
Published online: 04 Apr 2023
CitationforIn reply to: Significant heterogeneity of published literature comparing radiofrequency ablation versus stereotactic body radiation therapy for hepatocellular carcinoma | Full Text | References | PDF (1.2 MB) | EPUB
  • 30 Views
  • 0 CrossRef citations
  • 0Altmetric

Plain Language Summary of Publication

Plain Language Summary of Publication
Afatinib for the treatment of non-small-cell lung cancer with unusual EGFR mutations: a plain language summary
James Chih-Hsin Yang
Pages: 291-297
Published online: 16 Feb 2023
AbstractforAfatinib for the treatment of non-small-cell lung cancer with unusual EGFR mutations: a plain language summary | PDF (892.8 KB)
  • 1254 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Short Communication

Brief Report
A patient’s perspective on the side effects of tyrosine kinase inhibitors in the treatment of advanced and metastatic gastrointestinal stromal tumors
Deborah van de Wal, Shreenila Venkatesan, Charlotte Benson, Winette TA van der Graaf, Colin D Johnson, Olga Husson & Samantha C Sodergren
Pages: 299-314
Published online: 11 Apr 2023
AbstractforA patient’s perspective on the side effects of tyrosine kinase inhibitors in the treatment of advanced and metastatic gastrointestinal stromal tumors | Full Text | References | PDF (1.4 MB) | EPUB | Supplemental
  • 1138 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Research Article

Article
The value of pretreatment glucose-to-lymphocyte ratio for predicting survival of metastatic gastric cancer
Zekeriya Hannarici, Ali Yılmaz, Mehmet Emin Buyukbayram, Aykut Turhan, Alperen Akansel Çağlar, Mehmet Bilici & Salim Başol Tekin
Pages: 315-325
Published online: 09 Mar 2023
AbstractforThe value of pretreatment glucose-to-lymphocyte ratio for predicting survival of metastatic gastric cancer | Full Text | References | PDF (1.4 MB) | EPUB
  • 104 Views
  • 0 CrossRef citations
  • 0Altmetric

Review

Review Article
Extension of lymph node dissection in the surgical treatment of esophageal and gastroesophageal junction cancer: seven questions and answers
Alessio Vagliasindi, Filippo Di Franco, Maurizio Degiuli, Davide Papis & Marcello Migliore
Pages: 327-339
Published online: 21 Mar 2023
AbstractforExtension of lymph node dissection in the surgical treatment of esophageal and gastroesophageal junction cancer: seven questions and answers | Full Text | References | PDF (1.6 MB) | EPUB
  • 97 Views
  • 0 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

STELLAR-303: randomized phase III study of zanzalintinib + atezolizumab in previously treated metastatic colorectal cancer
Anwaar Saeed et al.
Method | Published online: 23 Jul 2024
Gastric cancer in pregnancy: a review
Hongming Liu et al.
Review Article | Published online: 23 Jul 2024
A novel prognostic index for extranodal natural killer/T-cell lymphoma in the era of pegaspargase/L-asparaginase
Ziyuan Shen et al.
Article | Published online: 23 Jul 2024
An investigator-initiated clinical study in patients with refractory or recurrent solid tumors: ‘R-ISV-FOLactis’ trial
Juanjuan Dai et al.
Method | Published online: 21 Jul 2024
View all latest articles